CheezhengTTM(SZ:002287) Xin Lang Zheng Quan·2025-09-12 09:12Core Viewpoint - The company, Tibet Qizheng Tibetan Medicine Co., Ltd., announced an adjustment to the maximum repurchase price of its shares following the implementation of its 2025 semi-annual profit distribution plan, reducing the price from 31.27 CNY to 31.05 CNY per share effective September 22, 2025 [1][4]. Group 1: Share Repurchase Overview - On February 27, 2025, the company's board approved a share repurchase plan using its own funds, with a total repurchase amount between 90 million CNY and 160 million CNY, and a maximum price of 31.65 CNY per share [2]. - The previous adjustment of the repurchase price limit from 31.65 CNY to 31.27 CNY was effective from July 10, 2025, due to the 2024 annual profit distribution [2]. Group 2: Semi-Annual Profit Distribution Details - On August 21, 2025, the board approved a profit distribution plan, distributing a cash dividend of 2.20 CNY per 10 shares (including tax), with a total cash dividend amounting to approximately 125.41 million CNY [3]. - The cash dividend per share, calculated based on the total share capital after excluding repurchased shares, is approximately 0.2192 CNY [3]. Group 3: Adjustment of Repurchase Price Limit - The new maximum repurchase price limit is calculated by subtracting the cash dividend per share from the previous limit, resulting in an adjusted price of approximately 31.05 CNY per share [4]. - As of August 31, 2025, the company had repurchased 2,673,910 shares, accounting for 0.47% of the total share capital, with a total transaction amount of approximately 83.70 million CNY [4]. - The estimated remaining repurchase amount allows for the acquisition of approximately 325,530 shares at the upper limit and about 100,090 shares at the lower limit, subject to actual repurchase quantities by the end of the repurchase period [4].